Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
Status:
Completed
Trial end date:
2017-03-14
Target enrollment:
Participant gender:
Summary
This study is an open label, multi-center, randomized trial, which is designed to evaluate
the efficacy and safety of clopidogrel derivative (Pregrel®) therapy for 12 months in
patients undergoing PCI compared to conventional clopidogrel (Plavix®).